Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 4, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • VACCINE
  • Page 4

Tag: VACCINE

  • BiotechToday
  • World

Molnupiravir: The real game-changer for COVID-19?

bioxone March 20, 2021March 20, 2021 3

Shagufta Hasan, Amity University Kolkata  The world has had hard knocks with COVID-19 vaccines but no drug seems to give full coverage against the virus, but now, it may hope for good news. A new drug, Molnupiravir, has been developed by Merck & Co. Inc in association with Ridgeback Biotherapeutics, a biotechnology company, focused on […]

Read More
  • BiotechToday
  • World

Priority Review for Pfizer’s tick-borne encephalitis vaccine in the US

bioxone March 4, 2021March 4, 2021 1

Devyani Goswami, Amity University Kolkata Nanette Cocero, global president, vaccines, of Pfizer announced that their tick-borne encephalitis vaccine (TBE) has been approved for a priority review from the US Food and Drug Administration (FDA).  Once approved the vaccine promises to cure tick-borne encephalitis epidemics all across the US. The vaccine has to be subjected twice […]

Read More
  • BiotechToday
  • World

D614G: NEW CORONAVIRUS MUTATIONS MAKES THE VIRUS EIGHT TIMES MORE INFECTIOUS

bioxone February 19, 2021February 19, 2021 4

Aishila Kar, Amity University Kolkata The research, confirms findings that D614G — one of many mutations in the concerning variants that have emerged in the UK, South Africa, and Brazil — makes the coronavirus 8times more infectious. This novel coronavirus, D614G mutation in the spike protein renders it up to 8 times more infectious in […]

Read More
  • BiotechToday
  • World

Do we have a vaccine for HIV now?!!!

bioxone February 12, 2021February 12, 2021 1

CAMELIA BHATTACHARYYA, AMITY UNIVERSITY KOLKATA HIV or Human Immunodeficiency virus was first discovered in the early 1980s. It later became an epidemic and it still scares people since there’s still no vaccine known to protect us against it. Does that mean that the scientists and researchers are not trying to even make one? Well no. […]

Read More
  • Biotechnopedia
  • DNA-Tales

Covid Update- Doom of the New Coronavirus Strain

bioxone January 22, 2021January 22, 2021 1

Ankita Chattopadhyay, Amity University Kolkata Previously, COVID19 was associated with the onset of numerous symptoms that ranged from mild to moderate severity, starting from cough and fever to complete loss of movement in some cases. Unusual numbers of people from all over the world started showing different sorts of symptoms with different severities, at some […]

Read More
  • BiotechToday
  • India

COVAXIN : India’s preparation for massive vaccination drive.

bioxone January 10, 2021January 9, 2021

-Chitra Roy, University of Calcutta Covaxin, India’s indigenous COVID-19 vaccine, has been a subject of criticism due to its approval for restricted emergency use despite hot having published any phase 3 efficacy data. However, until recently, Bharat Biotech, the manufacturer of Covaxin claimed that its vaccine potentially generated safety data with the robust immune response […]

Read More
  • BiotechToday
  • India

Oxford-AstraZeneca: CDSCO approved after several debates

bioxone January 2, 2021January 2, 2021 2

Camelia Bhattacharyya, Amity University Kolkata When dealing with treatments relating to human health, we need to take care of two things: i.) the cure should be developed on the basis of all criteria including the majority of the population, and ii.) side-effects should be absent or negligible. Any drug or vaccine to be identified safe, […]

Read More
  • BiotechToday
  • World

A stronger COVID-19 mutant found

bioxone December 29, 2020December 29, 2020 1

Husna, Amity University Kolkata Just as the world was waiting with hope for the vaccine to start off a healthier 2021, UK has cautioned to take necessary precautionary measures against a new contagious COVID-19 mutant. Scientists have stated that all viruses mutate as it’s in their nature to mutate, as the human body gets more […]

Read More
  • BiotechToday
  • World

American mink: The first wild animal infected with Coronavirus

bioxone December 26, 2020December 26, 2020 1

Ayooshi Mitra, Amity University, Kolkata There is currently no evidence of widespread transmission of SARS CoV-2 among wild animals, but recently, a wild American mink in Utah has tested positive for the virus — the first wild animal found to be infected with the Coronavirus, according to the researchers. According to the U.S. Department of […]

Read More
  • Biotechnopedia
  • DNA-Tales

Stages of Vaccine Development

bioxone December 10, 2020December 10, 2020 2

 Akash Pramamik,D.Y Patil Medical College, Kolhapur The past experiences have shown that the development of a vaccine is a long process and studies are done in sequential steps. Due to the recent outbreak of the coronavirus pandemic, the government along with the pharmaceutical companies are gearing up to develop a vaccine as soon as possible.  […]

Read More

Posts navigation

1 2 3 4 5 6 7

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy